Pfizer to share its expertise in clinical trials capabilities with DoH in Abu Dhabi – ITP.net

Pfizer to share its expertise in clinical trials capabilities with DoH in Abu Dhabi – ITP.net

The Department of Health – Abu Dhabi (DoH) has joined hands with Pfizer, one of the world’s premier biopharmaceutical companies, to develop national competencies and clinical research capacity in Abu Dhabi.

The mutual agreement will focus on developing clinical trials conduct and enhancing research efforts and medical processes in the emirate. Pfizer will support DoH in establishing a training curriculum that’s specialised in advancing the early phase of clinical trials and drug development programmes. The collaboration reflects the emirate’s continuous efforts to upgrade the digital health system and foster innovation in healthcare.

Pfizer will train up to 150 clinical researchers under the collaboration, who will also have an opportunity of research mentorship support by Pfizer research partner within two years and supporting DoH’s aim of reaching 500 qualified clinical researchers by 2025 through various collaborations and initiatives.